Teva Settles Gilead's HIV Drug Patent Suit As Trial Looms
Teva Pharmaceuticals USA Inc. has agreed to a settlement with Gilead Sciences Inc. to end a patent infringement dispute over its planned generic version of antiviral treatment Viread, heading off a...To view the full article, register now.
Already a subscriber? Click here to view full article